Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription Articles published in J Clin Invest Retrieve available abstracts of 26 articles: HTML format

Single Articles

February 2024
1. JAFFE IZ, Karumanchi SA
   Lipid droplets in the endothelium: The missing link between metabolic syndrome and cardiovascular disease?
   J Clin Invest. 2024;134:e176347.
   PubMed     Abstract available
   
   
   September 2023
2. THORP EB
   Cardiac macrophages and emerging roles for their metabolism after myocardial infarction.
   J Clin Invest. 2023;133:e171953.
   PubMed     Abstract available
   
   
   July 2023
3. YU Z, Filder TP, Ruan Y, Vlasschaert C, et al
   Genetic modification of inflammation and clonal hematopoiesis-associated cardiovascular risk.
   J Clin Invest. 2023 Jul 27:e168597. doi: 10.1172/JCI168597.
   PubMed     Abstract available
   
   
   
4. SATO M, Neufeld EB, Playford MP, Lei Y, et al
   Cell-free high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease.
   J Clin Invest. 2023 Jul 20:e165370. doi: 10.1172/JCI165370.
   PubMed     Abstract available
   
   
   June 2023
5. NAKAO T, Libby P
   IL-6 helps weave the inflammatory web during acute coronary syndromes.
   J Clin Invest. 2023;133:e167670.
   PubMed     Abstract available
   
   
   
6. ALTER C, Henseler AS, Owenier C, Hesse J, et al
   IL-6 in the infarcted heart is preferentially formed by fibroblasts and modulated by purinergic signaling.
   J Clin Invest. 2023;133:e163799.
   PubMed     Abstract available
   
   
   May 2023
7. QUIJADA P, Park S, Zhao P, Kolluri KS, et al
   Cardiac pericytes mediate the remodeling response to myocardial infarction.
   J Clin Invest. 2023;133:e162188.
   PubMed     Abstract available
   
   
   March 2023
8. LEYBAERT L, De Smet MA, Lissoni A, Allewaert R, et al
   Connexin hemichannels as candidate targets for cardioprotective and anti-arrhythmic treatments.
   J Clin Invest. 2023;133:e168117.
   PubMed     Abstract available
   
   
   February 2023
9. WEISSMAN D, Maack C
   Mitochondrial function in macrophages controls cardiac repair after myocardial infarction.
   J Clin Invest. 2023;133:e167079.
   PubMed     Abstract available
   
   
   
10. GARLAPATI V, Molitor M, Michna T, Harms GS, et al
    Targeting myeloid cell coagulation signaling blocks MAP kinase/TGF-beta1-driven fibrotic remodeling in ischemic heart failure.
    J Clin Invest. 2023;133:e156436.
    PubMed     Abstract available
    
    
    December 2022
11. GOODCHILD TT, Li Z, Lefer DJ
    Soluble urokinase plasminogen activator receptor: from biomarker to active participant in atherosclerosis and cardiovascular disease.
    J Clin Invest. 2022;132:e165868.
    PubMed     Abstract available
    
    
    
12. CAI S, Zhao M, Zhou B, Yoshii A, et al
    Mitochondrial dysfunction in macrophages promotes inflammation and suppresses repair after myocardial infarction.
    J Clin Invest. 2022 Dec 8:e159498. doi: 10.1172/JCI159498.
    PubMed     Abstract available
    
    
    
13. NAGARAJAN N, Oka SI, Nah J, Wu C, et al
    Thioredoxin 1 promotes autophagy through transnitrosylation of Atg7 during myocardial ischemia.
    J Clin Invest. 2022 Dec 8:e162326. doi: 10.1172/JCI162326.
    PubMed     Abstract available
    
    
    October 2022
14. GARRY DJ, Yannopoulos D, Alexy T
    Revolutionizing cardiovascular medicine: targeted therapies for the cardiac conduction system.
    J Clin Invest. 2022;132.
    PubMed     Abstract available
    
    
    September 2022
15. BLANCO-DOMINGUEZ R, de la Fuente H, Rodriguez C, Martin-Aguado L, et al
    CD69 expression on regulatory T cells protects from immune damage after myocardial infarction.
    J Clin Invest. 2022 Sep 6. pii: 152418. doi: 10.1172/JCI152418.
    PubMed     Abstract available
    
    
    June 2022
16. LAGGERBAUER B, Engelhardt S
    MicroRNAs as therapeutic targets in cardiovascular disease.
    J Clin Invest. 2022;132.
    PubMed     Abstract available
    
    
    May 2022
17. GLINTON KE, Ma W, Lantz C, Grigoryeva LS, et al
    Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation.
    J Clin Invest. 2022;132.
    PubMed     Abstract available
    
    
    March 2022
18. HENRION D
    Modulating the immune response to reduce hypertension-associated cardiovascular damage.
    J Clin Invest. 2022;132.
    PubMed     Abstract available
    
    
    February 2022
19. FAILER T, Amponsah-Offeh M, Neuwirth A, Kourtzelis I, et al
    Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation.
    J Clin Invest. 2022 Feb 8. pii: 126155. doi: 10.1172/JCI126155.
    PubMed     Abstract available
    
    
    
20. HUMERES C, Shinde AV, Hanna A, Alex L, et al
    Smad7 effects on TGF-beta and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure.
    J Clin Invest. 2022;132.
    PubMed     Abstract available
    
    
    January 2022
21. BAILEY LR, Davis J
    If these myocytes could talk, they would speak the language of metabolites.
    J Clin Invest. 2022;132.
    PubMed     Abstract available
    
    
    
22. MUSUNURU K
    Moving toward genome-editing therapies for cardiovascular diseases.
    J Clin Invest. 2022;132.
    PubMed     Abstract available
    
    
    November 2021
23. JIANG K, Tu Z, Chen K, Xu Y, et al
    Gasdermin D inhibition confers antineutrophil mediated cardioprotection in acute myocardial infarction.
    J Clin Invest. 2021 Nov 9. pii: 151268. doi: 10.1172/JCI151268.
    PubMed     Abstract available
    
    
    October 2021
24. BRAKENHIELM E, Chen Y, Cao Y
    Lymphatics in the broken heart.
    J Clin Invest. 2021;131.
    PubMed     Abstract available
    
    
    September 2021
25. KNUTSON AK, Williams AL, Boisvert WA, Shohet RV, et al
    HIF in the heart: development, metabolism, ischemia, and atherosclerosis.
    J Clin Invest. 2021;131.
    PubMed     Abstract available
    
    
    April 2021
26. KASIKARA C, Schilperoort M, Gerlach B, Xue C, et al
    Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis.
    J Clin Invest. 2021;131.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.